Tag Archives: Business Wire

engin Raises $2.5M in Seed Financing to Revolutionize Recruitment in Emerging Industries

NEW YORK–(BUSINESS WIRE)–Engin Sciences Inc. (“engin”), an AI-powered recruitment software startup, today announced a $2.5 million seed funding round led by investment firm Gotham Green Partners. engin’s cutting-edge technology streamlines job advertising and recruitment for companies, delivering high intent applicants, accelerated hiring, and significant cost savings. As emerging industries like cannabis experience rapid growth across the United States, companies need to fill hundreds of tho

yourchat.ai launches ChatGPT and AI Internet Search via Messenger or Web App in Italian language and compliant with GDPR

LARNACA, Cyprus–(BUSINESS WIRE)–Technology startup, yourchat.ai Ltd., today announces the launch of its innovative AI services via ChatGPT, yourchat.ai and yoursearch.ai, to the Italian market. yourchat.ai offers ChatGPT in a compact way via messenger or WebApp, which is easier to use, GDPR-compliant and cost-free. Users can also receive images from the AI via messenger, using only a text description. On yoursearch.ai, users first enter their search query in a web app or messenger. The chatbo

Acquisition of Compression Components and Services, LLC Bolsters Operio Group’s Position in the Solid Dose Market

FORT WORTH, Texas–(BUSINESS WIRE)–Operio Group acquires CCS to expand its presence in solid dose manufacturing. This will extend the reach of CCS to international solid dose markets.

Phibro Animal Health Corporation to Participate in Bank of America Securities 2023 Health Care Conference.

TEANECK, N.J.–(BUSINESS WIRE)–Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America Securities 2023 Health Care Conference. Chief Financial Officer Damian Finio will address financial analysts and investors on Tuesday, May 9, 2023, at 4:20 PM PDT. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investors.pahc.com. A replay of the session will be available and archiv

Virpax Reports on Progress of Envelta™

BERWYN, Pa.–(BUSINESS WIRE)– #pharma–Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indications, today announced recent progress made in its Envelta development program. Envelta is the Company’s non-opioid pain product candidate for acute and chronic pain that is being funded under an in-kind grant from the

Panda Biotech Announces Landmark Equity Partnership With Southern Ute Growth Fund Aka-Ag, LLC

DALLAS–(BUSINESS WIRE)–Panda Biotech announces a landmark equity partnership deal between the Panda High Plains Hemp Gin™ (PHPHG) project and the Southern Ute Indian Tribe Growth Fund (Growth Fund). The Growth Fund is owned by the Southern Ute Indian Tribe, a federally recognized tribe. The strategic alliance was inked with Aka-Ag, LLC, a Growth Fund subsidiary. The investment marks a significant advancement toward PHPHG’s much-anticipated Q4 2023 launch. Located in Wichita Falls, Texas, PHPH

Flora Growth Receives CGMP Certification of Compound Formulation Lab; Launches Prescription Cannabis Medicines in Colombia

FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading cultivator, manufacturer and distributor of global cannabis products and brands, announced today the certification of its Bogotá-based compound formulation laboratory, Flora Lab 4, following the required regulatory inspection by INVIMA (Colombia’s FDA). The inspection certifies the lab as meeting Current Good Manufacturing Practices standards as determined by INVIMA. Flora Lab 4 spec

Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016-2023 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016-2023” report has been added to ResearchAndMarkets.com’s offering. The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016-2023 report provides comprehensive understanding and unprecedented access to the joint venture deals and agreements entered into by the worlds leading life science companies. This report provides details of the la

Conduction Vaporizers Global Market Report 2023: Increased Adoption of Safer Substitutes for Cigarettes Bolsters Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Conduction Vaporizers Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031” report has been added to ResearchAndMarkets.com’s offering. The global conduction vaporizers market is expected to grow at a CAGR of 15% during the forecast period of 2023 to 2031. As more individuals learn about the health benefits of vaporization and the dangers of smoking, the demand for vaporize

Organigram to Report Second Quarter Fiscal 2023 Results on April 11, 2023

TORONTO–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its second quarter fiscal 2023 ended February 28, 2023, on Tuesday, April 11, 2023, after market close. The Company will host a conference call to discuss its results with details as follows: Date: Wednesday, April 12, 2023 Time: 8:00 am Eastern Ti

Global Gastrointestinal Agents Industry Report to 2030: North America Dominates the Market – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Gastrointestinal Agents Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030” report has been added to ResearchAndMarkets.com’s offering. The report offers strategic insights into the overall gastrointestinal agents market along with the market size and estimates for the duration 2020 to 2030. Companies Mentioned Abbott Laboratories Allergan Plc. (Formerly Actavis Plc.) Ast

Delic Holdings Corp. Signs LOI with Peter/PetraMD to Acquire Ketamine Wellness Centers and Facilitate Online Ketamine Treatments Nationwide

VANCOUVER, British Columbia–(BUSINESS WIRE)–Peter/PetraMD, the largest online provider of hormone therapy for men and women in the United States, today announced the intent to acquire Ketamine Wellness Centers. If successful, the acquisition would represent an incredible on-ramp into the ketamine space for Peter/PetraMD. With over 20 years of experience and nearly 100,000 patients across the United States, Ketamine Wellness Centers is the largest ketamine infusion therapy provider in the US a